What should we learn from the COVID pandemic for public
and population health going forward?
Session Leader: Amesh Adalja, Senior Scholar at the Johns Hopkins University Center for Health Security. Dr. Adalja is a global expert on pandemics and their consequences for public health, and population health.
The Forum focused on the lessons of the COVID pandemic, and how C-Suite executives in healthcare and the life sciences should respond.
How will the pandemic affect demand and funding for infectious disease treatment innovation?
Is there a new role for C-Suite leaders in public and population health policies?
What may change in relations between industry, the FDA, and approval processes?
How can leaders capture and sustain the improved reputation of healthcare and the life sciences flowing from the vaccine victories?
How is that reputation impacted by the issues around safety and supply?